Skip to main content
HLB Pep Co., Ltd. logo

HLB Pep Co., Ltd. — Investor Relations & Filings

Ticker · 196300 ISIN · KR7196300008 KO Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2025-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 196300

About HLB Pep Co., Ltd.

http://hlbpep.co.kr/eng/main/

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Anygen Co., Ltd.' (애니젠 주식회사). It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements for the fiscal years 2023 and 2024. While it contains financial data, it is specifically the audited financial report package, which falls under the 'Audit Report / Information' category in the provided schema. FY 2024
2025-03-21 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by '주식회사 코아스' in '애니젠㈜' through a third-party capital increase. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) as it tracks changes in significant ownership levels.
2025-03-20 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) titled '증권 발행결과' (Securities Issuance Result). It details the completion of a third-party capital increase (유상증자), including the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2025-03-19 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korean stock exchange (KRX) titled 'Change of Largest Shareholder' (최대주주변경). It details the change in ownership structure, the reason for the change (third-party capital increase), and provides specific details about the new controlling entity. This type of disclosure is a standard regulatory requirement for listed companies to inform the market of significant changes in control, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to corporate mergers/acquisitions of the company itself) or Director's Dealing.
2025-03-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. It details the shareholding changes of a registered executive (Kim Jae-il) of Anygen Co., Ltd. due to forced sales (margin calls). This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which falls under the 'Director's Dealing' category.
2025-03-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership by a major shareholder (Kim Jae-il) of Anygen Co., Ltd., specifically noting 'disposal in the market' (장내매도) and 'forced sale due to collateral execution' (담보권 실행에 의한 반대매매). This type of filing is a standard regulatory disclosure for significant changes in shareholding thresholds, which falls under the 'Major Shareholding Notification' category.
2025-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.